Gabapentin and pregabalin: New safety concerns issued by the FDA in America | 25 February 2020
US FDA issue new safety concerns about the drugs and their use in people who have significant respiratory illnesses.
US FDA issue new safety concerns about the drugs and their use in people who have significant respiratory illnesses.